16,350€
3,48%
Echtzeit-Aktienkurs Anika Therapeutics Inc.
Bid:
Ask:
Echtzeit-Chart der Anika Therapeutics Inc. Aktie
Börsenkurse Anika Therapeutics Inc.
| gettex | - | - | - | - | 16,350€ | -1,80% |
| Börse Stuttgart | - | - | - | - | 16,300€ | -0,61% |
| Lang & Schwarz | - | - | - | - | 16,300€ | -2,10% |
| Börse Frankfurt | - | - | - | - | 16,350€ | 3,48% |
| USA | - | - | - | - | 16,970$ | -1,22% |
| Nasdaq | - | - | - | - | 16,970$ | -2,81% |
| Echtzeit Euro | - | - | - | - | 16,350€ | -0,30% |
| Echtzeit USD | - | - | - | - | 16,990$ | -2,53% |
Fundamentaldaten der Anika Therapeutics Inc. Aktie
Aktuelle Geschäftsentwicklung
Sie benötigen die TraderFox Börsensoftware, um die aktuelle Geschäftsentwicklung einsehen zu können.
Income Statement: 10-Year-Summary
| Datum | Umsatz | EBIT | Gewinn | EPS | Dividende | KGV | KUV |
|---|---|---|---|---|---|---|---|
| 2023 [USD] | 166,66 Mio. | -85,33 Mio. | -82,67 Mio. | -5,64 | - | - | 1,44 |
| 2022 [USD] | 156,24 Mio. | -18,75 Mio. | -14,86 Mio. | -1,02 | - | - | 1,53 |
| 2021 [USD] | 147,79 Mio. | 2,43 Mio. | 4,13 Mio. | 0,28 | - | 57,98 | 1,60 |
| 2020 [USD] | 130,46 Mio. | -28,62 Mio. | -23,98 Mio. | -1,69 | - | - | 1,80 |
| 2019 [USD] | 114,61 Mio. | 36,12 Mio. | 27,19 Mio. | 1,89 | - | 8,64 | 2,04 |
| 2018 [USD] | 105,56 Mio. | 23,21 Mio. | 18,72 Mio. | 1,28 | - | 12,82 | 2,20 |
| 2017 [USD] | 113,42 Mio. | 46,20 Mio. | 31,82 Mio. | 2,11 | - | 7,75 | 2,12 |
| 2016 [USD] | 103,38 Mio. | 50,87 Mio. | 32,55 Mio. | 2,15 | - | 7,60 | 2,31 |
| 2015 [USD] | 93,00 Mio. | 48,25 Mio. | 30,76 Mio. | 2,01 | - | 8,13 | 2,64 |
| 2014 [USD] | 105,59 Mio. | 61,51 Mio. | 38,32 Mio. | 2,51 | - | 6,51 | 2,30 |
| Die Multiples wie die KGVs werden mit der Bilanzwährung und dem Kurs des ausgewählten Börsenplatzes berechnet. Wählen Sie den Börsenplatz mit der Bilanzwährung aus, damit die Multiples korrekt sind. Die fundamentalen Daten werden von Facunda geliefert; Multiples werden mit dem aktuellen Kurs berechnet. | |||||||
Profil der Anika Therapeutics Inc. Aktie
Anika Therapeutics, Inc. is a global joint preservation company that creates and delivers meaningful advancements in early intervention orthopedic care. Its products are based on hyaluronic acid, a natural chemical occurring, biocompatible polymer found throughout the body. It offers therapeutic products which include orthobiologics, dermal, ophthalmic, surgical, ophthalmic and veterinary. The company's main focus is on high opportunity spaces within orthopedics, including Osteoarthritis Pain Management, Regenerative Solutions, Sports Medicine and Arthrosurface Joint Solutions, and its products are efficiently delivered in key sites of care, including ambulatory surgery centers. Anika Therapeutics was founded in 1992 and is headquartered in Bedford, MA.